Volver a ensayos clínicos
NCT00063141 Archived Fase 3

Estudio de irinotecán y cetuximab frente a irinotecán como tratamiento de segunda línea en pacientes con cáncer colorrectal metastásico y EGFR positivo.

Guardar ClinicalTrials.gov

Descripción

El objetivo de este estudio es determinar si la supervivencia global se prolonga en pacientes con cáncer colorrectal metastásico, positivo para el receptor del factor de crecimiento epidérmico (EGFR), tratados con cetuximab en combinación con irinotecán, en comparación con el tratamiento con irinotecán solo, como terapia de segunda línea tras el tratamiento con un régimen basado en fluoropirimidina y oxaliplatino que no contenga irinotecán.

Qué se prueba

Fármacos del ensayo

Biomarcadores que menciona

EGFR

Pueden ser requisito para entrar o para quedar fuera: los criterios de elegibilidad dicen cuál.

Evidencia de la diana molecular en cáncer colorrectal

Estos fármacos NO son el fármaco de este ensayo. Es la eficacia publicada de OTROS fármacos que atacan la misma diana molecular, mostrada como contexto — no se refiere a este ensayo concreto ni confirma elegibilidad. Revísalo siempre con tu oncólogo.

Aún no hay evidencia documentada en nuestra base para la diana o el fármaco de este ensayo. Esta sección crece a medida que se procesan nuevas publicaciones.

Criterios de elegibilidad

SexoTodos
Edad18 años o más
Voluntarios sanosNo

Criterios de inclusión:

  • Cáncer colorrectal histológicamente confirmado, que sea EGFR-positivo según inmunohistoquímica \[IHC] (puede basarse en muestras de archivo) y que sea metastásico.
  • Administración previa de oxaliplatino para el tratamiento de primera línea del cáncer colorrectal metastásico.
  • Administración previa de un régimen que contenga fluoropirimidina (5-fluorouracilo \[5-FU], capecitabina o uracilo/tegafur \[UFT]) para el tratamiento de primera línea de la enfermedad metastásica.

Criterios de exclusión:

  • Un trastorno médico grave no controlado que, en opinión del investigador, impida la capacidad del sujeto para recibir la terapia del protocolo.
  • Diarrea no resuelta, obstrucción intestinal o antecedentes de enfermedad inflamatoria intestinal.
  • Metástasis cerebrales conocidas o documentadas.

Avísame de ensayos parecidos

Cuando se abra un ensayo nuevo en España para estos biomarcadores, te lo enviamos. Sin registro.

Información del ensayo

Número NCT
NCT00063141
Estado
Archived
Fase
Fase 3
Tipo de estudio
Intervencional (prueba un tratamiento)
Inscripción
1.302 participantes
Fecha de inicio
Abr 2003
Finalización prevista
Patrocinador
Eli Lilly and Company

Ubicaciones188

Australia (7)
ImClone Investigational Site
Wien
ImClone Investigational Site
Perth, Australian Capital Territory
ImClone Investigational Site
Sydney, Australian Capital Territory
ImClone Investigational Site
Sydney, New South Wales
ImClone Investigational Site
Wollongong, New South Wales
ImClone Investigational Site
South Brisbane, Queensland
ImClone Investigational Site
Adelaide, South Australia
Austria (4)
ImClone Investigational Site
Graz
ImClone Investigational Site
Salzburg
ImClone Investigational Site
Vienna
ImClone Investigational Site
Wein
Bélgica (1)
ImClone Investigational Site
Charleroi
Chequia (3)
ImClone Investigational Site
Brno
ImClone Investigational Site
Olomouc
ImClone Investigational Site
Prague
Finlandia (1)
ImClone Investigational Site
Helsinki
Francia (4)
ImClone Investigational Site
Avignon
ImClone Investigational Site
Marseille
ImClone Investigational Site
Nice
ImClone Investigational Site
Saint-Herblain
Alemania (18)
ImClone Investigational Site
Aschaffenburg
ImClone Investigational Site
Augsburg
ImClone Investigational Site
Dessau
ImClone Investigational Site
Dortmund
ImClone Investigational Site
Essen
ImClone Investigational Site
Hamburg
ImClone Investigational Site
Hanburg
ImClone Investigational Site
Kaiserslautern
ImClone Investigational Site
Kassel
ImClone Investigational Site
Magdeburg
ImClone Investigational Site
Mainz
ImClone Investigational Site
Mannheim
ImClone Investigational Site
Muchnhen
ImClone Investigational Site
München
ImClone Investigational Site
Regensburg
ImClone Investigational Site
Saarbrücken
ImClone Investigational Site
Stralsund
ImClone Investigational Site
Stuttgart
Hong Kong (1)
ImClone Investigational Site
Hong Kong
Italia (14)
ImClone Investigational Site
Ancona
ImClone Investigational Site
Bergamo
ImClone Investigational Site
Candiolo
ImClone Investigational Site
Florence
ImClone Investigational Site
Genova
ImClone Investigational Site
Livomo
ImClone Investigational Site
Milan
ImClone Investigational Site
Modena
ImClone Investigational Site
Napoli
ImClone Investigational Site
Perugia
ImClone Investigational Site
Reggio Emilia
ImClone Investigational Site
Roma
ImClone Investigational Site
Rome
ImClone Investigational Site
Rozzano, Milano
Países Bajos (2)
ImClone Investigational Site
Apeldoorn
ImClone Investigational Site
Dordrecht
Noruega (2)
ImClone Investigational Site
Oslo
ImClone Investigational Site
Montebello, Oslo County
Portugal (1)
ImClone Investigational Site
Porto
Eslovaquia (1)
ImClone Investigational Site
Bratislava
Suecia (2)
ImClone Investigational Site
Lund
ImClone Investigational Site
Stockholm
Suiza (3)
ImClone Investigational Site
Bern
ImClone Investigational Site
Liestal
ImClone Investigational Site
Zurich
Reino Unido (8)
ImClone Investigational Site
Foresterhill, Aberdeenshire
ImClone Investigational Site
Hull, Avon
ImClone Investigational Site
Glasgow, Central
ImClone Investigational Site
Poole, Dorset
ImClone Investigational Site
London, Greater London
ImClone Investigational Site
Bournemouth, Hampshire
ImClone Investigational Site
Guildford, Surrey
ImClone Investigational Site
Sutton, Surrey
Estados Unidos (116)
ImClone Investigational Site
Tucson, Arizona
ImClone Investigational Site
Pine Bluff, Arkansas
ImClone Investigational Site
Bakersfield, California
ImClone Investigational Site
Berkeley, California
ImClone Investigational Site
Beverly Hills, California
ImClone Investigational Site
Corona, California
ImClone Investigational Site
Gilroy, California
ImClone Investigational Site
Greenbrae, California
ImClone Investigational Site
Long Beach, California
ImClone Investigational Site
Los Angeles, California
ImClone Investigational Site
Los Angeles, California
ImClone Investigational Site
Montebello, California
ImClone Investigational Site
Orange, California
ImClone Investigational Site
Palm Springs, California
ImClone Investigational Site
Rancho Mirage, California
ImClone Investigational Site
San Diego, California
ImClone Investigational Site
Stockton, California
ImClone Investigational Site
Vallejo, California
ImClone Investigational Site
Aurora, Colorado
ImClone Investigational Site
Denver, Colorado
ImClone Investigational Site
New Haven, Connecticut
ImClone Investigational Site
New London, Connecticut
ImClone Investigational Site
Norwich, Connecticut
ImClone Investigational Site
Stamford, Connecticut
ImClone Investigational Site
Fort Myers, Florida
ImClone Investigational Site
Fort Myers, Florida
ImClone Investigational Site
Inverness, Florida
ImClone Investigational Site
Jacksonville, Florida
ImClone Investigational Site
Jacksonville, Florida
ImClone Investigational Site
Jacksonville, Florida
ImClone Investigational Site
Lakeland, Florida
ImClone Investigational Site
Miami, Florida
ImClone Investigational Site
New Port Richey, Florida
ImClone Investigational Site
Orlando, Florida
ImClone Investigational Site
Port Saint Lucie, Florida
ImClone Investigational Site
Atlanta, Georgia
ImClone Investigational Site
Atlanta, Georgia
ImClone Investigational Site
Columbus, Georgia
ImClone Investigational Site
Macon, Georgia
ImClone Investigational Site
Savannah, Georgia
ImClone Investigational Site
Tucker, Georgia
ImClone Investigational Site
Honolulu, Hawaii
ImClone Investigational Site
Naperville, Illinois
ImClone Investigational Site
South Bend, Indiana
ImClone Investigational Site
Kansas City, Kansas
ImClone Investigational Site
Overland Park, Kansas
ImClone Investigational Site
Lexington, Kentucky
ImClone Investigational Site
Louisville, Kentucky
ImClone Investigational Site
Richmond, Kentucky
ImClone Investigational Site
Baton Rouge, Louisiana
ImClone Investigational Site
Lafayette, Louisiana
ImClone Investigational Site
Metairie, Louisiana
ImClone Investigational Site
Shreveport, Louisiana
ImClone Investigational Site
Baltimore, Maryland
ImClone Investigational Site
Frederick, Maryland
ImClone Investigational Site
Boston, Massachusetts
ImClone Investigational Site
Ann Arbor, Michigan
ImClone Investigational Site
Detroit, Michigan
ImClone Investigational Site
Southfield, Michigan
ImClone Investigational Site
Minneapolis, Minnesota
ImClone Investigational Site
Robbinsdale, Minnesota
ImClone Investigational Site
Saint Louis Park, Minnesota
ImClone Investigational Site
Jackson, Mississippi
ImClone Investigational Site
Kansas City, Missouri
ImClone Investigational Site
Rolla, Missouri
ImClone Investigational Site
St Louis, Missouri
ImClone Investigational Site
Trenton, New Jersey
ImClone Investigational Site
Voorhees Township, New Jersey
ImClone Investigational Site
Albany, New York
ImClone Investigational Site
East Setauket, New York
ImClone Investigational Site
Latham, New York
ImClone Investigational Site
Mineola, New York
ImClone Investigational Site
New York, New York
ImClone Investigational Site
Rexford, New York
ImClone Investigational Site
Stony Brook, New York
ImClone Investigational Site
The Bronx, New York
ImClone Investigational Site
Valhalla, New York
ImClone Investigational Site
Durham, North Carolina
ImClone Investigational Site
Greenville, North Carolina
ImClone Investigational Site
High Point, North Carolina
ImClone Investigational Site
Raleigh, North Carolina
ImClone Investigational Site
Winston-Salem, North Carolina
ImClone Investigational Site
Winston-Salem, North Carolina
ImClone Investigational Site
Bismarck, North Dakota
ImClone Investigational Site
Cincinnati, Ohio
ImClone Investigational Site
Cleveland, Ohio
ImClone Investigational Site
Columbus, Ohio
ImClone Investigational Site
Dayton, Ohio
ImClone Investigational Site
Newark, Ohio
ImClone Investigational Site
Oklahoma City, Oklahoma
ImClone Investigational Site
Hershey, Pennsylvania
ImClone Investigational Site
Philadelphia, Pennsylvania
ImClone Investigational Site
Philadelphia, Pennsylvania
ImClone Investigational Site
Philadelphia, Pennsylvania
ImClone Investigational Site
Pittsburgh, Pennsylvania
ImClone Investigational Site
Greenville, South Carolina
ImClone Investigational Site
Knoxville, Tennessee
ImClone Investigational Site
Memphis, Tennessee
ImClone Investigational Site
Nashville, Tennessee
ImClone Investigational Site
Austin, Texas
ImClone Investigational Site
Dallas, Texas
ImClone Investigational Site
Houston, Texas
ImClone Investigational Site
Plano, Texas
ImClone Investigational Site
Temple, Texas
ImClone Investigational Site
Ogden, Utah
ImClone Investigational Site
Arlington, Virginia
ImClone Investigational Site
Danville, Virginia
ImClone Investigational Site
Newport News, Virginia
ImClone Investigational Site
Richmond, Virginia
ImClone Investigational Site
Seattle, Washington
ImClone Investigational Site
Spokane, Washington
ImClone Investigational Site
Spokane, Washington
ImClone Investigational Site
Walla Walla, Washington
ImClone Investigational Site
Green Bay, Wisconsin
ImClone Investigational Site
Madison, Wisconsin
ImClone Investigational Site
Milwaukee, Wisconsin

Los hospitales y su estado vienen de ClinicalTrials.gov. Antes de desplazarte, confirma con el hospital que siguen incluyendo pacientes.

Esta ficha resume el registro oficial del ensayo. Si te interesa, coméntalo con tu oncólogo: es quien puede valorar si encajas y derivarte.